The intersection of business, science, and the law poses unique challenges for life sciences companies. Morgan Lewis understands the ramifications of that critical connection, and our lawyers work efficiently and strategically to solve the business, transactional, regulatory, intellectual property, litigation, and related issues our clients encounter throughout the product life cycle.
Our global life sciences capabilities were developed specifically to serve the pharmaceutical, biotechnology, medical device, and related industries, as well as the entities that invest in them, such as venture capital and private equity funds.
Morgan Lewis is a cross-border, full-service law firm that handles a broad range of matters for clients in the life sciences sector—from innovation and emerging-business issues through research, development and regulatory approval; marketing and distribution; product reimbursement; fraud, abuse, product liability, and intellectual property litigation; licensing and collaborations, mergers, acquisitions, and other corporate transactions; and outsourcing.
Our comprehensive cross-practice life sciences team is made up of more than 250 global partners and counsel, including more than 60 professionals with advanced scientific degrees. Our team members work from offices across the United States, Asia, Europe, and the Middle East, with a network of additional resources in Latin America and Africa. No matter the location, we have the capability to advise life sciences companies on the wide array of transactional and regulatory matters they face throughout the world.
Morgan Lewis’s commitment to the life sciences industry is reflected in our participation in premier life sciences organizations such as BIO, including regional chapters MassBio, BioNJ, and Life Sciences Pennsylvania. Our lawyers are thought leaders in the field, publishing client alerts and articles on timely topics affecting the industry and presenting at industry professional conferences around the world on trending life sciences subjects.
Morgan Lewis has handled some of the most complex and far-reaching licensing and collaboration transactions ever accomplished for life sciences companies around the globe. Our clients include more than 1,000 life sciences businesses, ranging from large and mid-sized pharmaceutical and biotechnology companies, healthcare providers, insurers, and product manufacturers to emerging biopharma, medical device, and digital health companies. We also advise companies in the immunology, virology, pharmaceutical chemistry, molecular biology, and bioinformatics industries.
In addition to global pharmaceutical companies, biotechs, and medical device companies, we count among our clients: